Confronto

Buserelin vs. Semax

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

57982-77-1

80714-61-0

Peso molecolare

1239.42 g/mol

813.92 g/mol

Emivita

nessun dato

0.3 h

Sequenza

nessun dato

Met-Glu-His-Phe-Pro-Gly-Pro

Meccanismo d'azione

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Semax

Semax is a tetracosactide fragment analog without hormonal activity at MC2R. Proposed mechanisms include elevation of BDNF and NGF in hippocampus and striatum (in animal models), modulation of dopamine metabolism, and neuroprotective effects via anti-apoptotic pathways. A clear primary receptor is not established.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Buserelin	Semax
Germania	Su prescrizione	Non approvato
RU	—	Su prescrizione
Stati Uniti	Non approvato	Non approvato

Voci complete

Frequently asked questions

What is the difference between Buserelin and Semax?: Buserelin is classified as "Ricerca (altro)", while Semax is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Semax?: The highest available evidence level is "RCT sull'uomo" for Buserelin and "Studio sull'uomo" for Semax. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Semax in Germany and the United States?: Germania: Buserelin — Su prescrizione, Semax — Non approvato. Stati Uniti: Buserelin — Non approvato, Semax — Non approvato. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Semax

Germania

Su prescrizione

Non approvato

—

Su prescrizione

Stati Uniti

Non approvato

Frequently asked questions

What is the difference between Buserelin and Semax?

Buserelin is classified as "Ricerca (altro)", while Semax is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Semax?

The highest available evidence level is "RCT sull'uomo" for Buserelin and "Studio sull'uomo" for Semax. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Semax in Germany and the United States?

Germania: Buserelin — Su prescrizione, Semax — Non approvato. Stati Uniti: Buserelin — Non approvato, Semax — Non approvato. These are factual summaries with source and review date on the individual pages.